Hepatitis C virus NS5A inhibitors and drug resistance mutations

Figure 2 Prevalence of naturally occurring resistance variants against hepatitis C virus NS5A in previous reports. Each bar represents an NS5A terminal protein with amino acid numbers. Letters within the bars represent the dominant amino acid at the indicated positions (prevalence %). Letters below the bars represent minor amino acids, and amino acids’ prevalence (%) is shown in parentheses. Genotype (GT) 1a, based on Ref[40] (n = 548) and Ref[68](n = 538); GT1b, based on Ref[40] (n = 1796) and Ref[68](n = 239); GT2, based on Los Alamos HCV data-base (n = 43 and n = 101 for GT2a and GT2b, respectively); GT3a, based on Ref[57] (n = 454); GT4, based on Ref[58] (n = 40).